The London Project To Cure Blindness – An Update
March 10, 2010
Last April, as part of a roundup of emerging technologies for treating AMD, I wrote about the London Project to Cure Blindness. (see: AMD Update 5). The group are planning on using embryonic stem cells placed on a membrane and inserted into the back of the retina to regenerate a patient’s retinal pigment epithelial (RPE) cells to restore function. This treatment is intended to be used in both dry and wet AMD.
Recently I made contact with the team and asked for an update on their progress.
They sent back information about the current status of the program, telling me that they are about to move into safety studies, required by their health authorities prior to commencing human clinical trials, which they hope to begin in the first quarter of 2011.
For the complete report, please see AMD Update 7 on my online Journal.
You might also enjoy...
- Current Status of Stem Cells and Gene Therapy in Ophthalmology
- Advanced Cell Technology, OHSU Researchers Show Safety, Efficacy of Human Embryonic Stem Cell (hESC)-Derived Retinal Pigment Epithelium (RPE)
- Embryonic Stem Cell Treatment for AMD
- Advanced Cell Technology Files Application for Trial to Treat Dry AMD With Human Embryonic Stem Cells
- Will Electronic Contact Lens Make Bionic Vision a Reality?
Jump down to form below to submit your own comments